CJ Foods announced that it entered into a joint development agreement (JDA) with T&R Biofab to develop alternative meat using 3D bioprinting technology. T&R Biofab is a med-tech company that develops artificial tissues using its world-class technology in the field of regenerative medicine based on 3D bioprinting. Through this collaboration, the two innovative Korean companies will leverage synergies between the food industry and the 3D printing medical field to elevate new plant-based alternative protein products up to consumers' expectations on taste, texture, appearance, and nutrition.

Plant-based alternative protein food products beyond the limitations of today's offerings are seen as new growth engines for both companies. According to Bloomberg Intelligence, the plant-based food market is estimated to be worth USD 162 billion by 2030, showing a rapid growth from USD 24.9 billion in 2020. Plant-based food has emerged as a major trend, extending beyond concerns about animal welfare to be recognized for its positive impact on health, nutrition, and environmental.

Nevertheless, one challenge has persisted achieving the authentic texture and mouthfeel of animal-based food. CJ Foods remains committed to developing and investing technologies aimed at securing sustainable food for the future. Notably, it launched a brand specializing in plant-based foods and offers plant-based Mandu products in both overseas and Korean markets.

In addition, last year, CJ Foods introduced a plant-based beverage brand, Altive, through its in-house food venture program known as INNO 100.